News

Stem cell therapy using iPSC technology on the surface of the eye could cure blindness by replacing damaged corneal cells – a ...
AbOliGo closes an oversubscribed seed round to scale AOC manufacturing, expand its team, and drive multiomic research growth.
MaxCyte licenses its ExPERT™ platform to Adicet Bio to advance allogeneic gamma delta T cell cancer and autoimmune therapies.
A new generation of malaria drugs failed clinical trials, in part because they were hard to swallow. UCSF chemists remodeled ...
EVERSANA launches an 80% AI-powered pharma marketing agency built on Google Cloud to cut costs and speed brand campaigns.
PacBio’s new Platinum Pedigree dataset improves AI variant calling accuracy by 34%, setting a new standard in genomics.
A new therapeutic system developed at Columbia Engineering uses engineered bacteria to deliver an oncolytic virus directly ...
Using artificial intelligence, researchers have come up with a new way to design nanoparticles that can more efficiently ...
Attendees will gain insight into how these human cell-based models provide a more accurate representation of in vivo biology, ...
Weill Cornell Medicine researchers discovered that gut neurons produce adrenomedullin 2 (ADM2), which supports immune cell ...
Preterm babies with very low birth weight who received a probiotic alongside antibiotics had fewer multidrug-resistant ...
A new study from Loughborough University has explored how gender-affirming hormone therapy affects the athletic performance ...